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Abstract
Background: Neurotransmitters are important regulators of the immune system, with very
distinct and varying effects on different leukocyte subsets. So far little is known about the impact
of signals mediated by neurotransmitters on the function of CD8+ T lymphocytes. Therefore, we
investigated the influence of norepinephrine, dopamine and substance P on the key tasks of CD8+
T lymphocytes: activation, migration, extravasation and cytotoxicity.
Results: The activation of naïve CD8+ T lymphocytes by CD3/CD28 cross-linking was inhibited by
norepinephrine and dopamine, which was caused by a downregulation of interleukin (IL)-2
expression via Erk1/2 and NF-κB inhibition. Furthermore, all of the investigated neurotransmitters
increased the spontaneous migratory activity of naïve CD8+ T lymphocytes with dopamine being
the strongest inducer. In contrast, activated CD8+ T lymphocytes showed a reduced migratory
activity in the presence of norepinephrine and substance P. With regard to extravasation we found
norepinephrine to induce adhesion of activated CD8+ T cells: norepinephrine increased the
interleukin-8 release from endothelium, which in turn had effect on the activated CXCR1+ CD8+
T cells. At last, release of cytotoxic granules from activated cells in response to CD3 cross-linking
was not influenced by any of the investigated neurotransmitters, as we have analyzed by measuring
the β-hexosamidase release.
Conclusion: Neurotransmitters are specific modulators of CD8+ T lymphocytes not by inducing
any new functions, but by fine-tuning their key tasks. The effect can be either stimulatory or
suppressive depending on the activation status of the cells.
Background
Almost two decades ago the observation has been made
that lymphoid organs are directly innervated, mostly by
neuropeptidergic fibers, and the question was raised
whether the supplied neurotransmitters might have
immunomodulatory functions [1,2]. This finding pro-
vided an anatomical rationale for the investigation of the
effects of neurotransmitters on leukocytes, especially on B
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and T lymphocytes. It turned out, that several neurotrans-
mitters have very distinct and varying functions on differ-
ent leukocyte subsets (for overview see [3]). However, up
to now there is no clear pattern of how the neuro-endo-
crine system in its function as the superordinate regula-
tory organ of the body modulates the immune system in
common. This is due to the complexity of both organ sys-
tems and their multilayer interaction. Consequently, the
discussion is still ongoing if and how emotions and sen-
sations are translated into a general stimulation or sup-
pression of the immune system.
Nevertheless, a large number of reports have been pub-
lished that describe the function of neurotransmitters on
certain leukocytes. Best characterized is probably the func-
tion of norepinephrine. This neurotransmitter is of special
interest, since it is not only locally released from sympa-
thetic nerve cells, but is also systemically disseminated
after release from the adrenal gland. Furthermore, cate-
cholaminergic innervation of lymph nodes increases
under psycho-social stress conditions, as was shown on
macaques [4]. T and B lymphocytes both express the β2-
adrenoceptor, which is responsible for the intracellular
signal transduction of norepinephrine. However, it is
unclear whether both activated T helper (Th)1 and Th2
lymphocytes, or only activated Th1 lymphocytes express
the β2-adrenoceptor [5]. In Th1 lymphocytes, norepine-
phrine has influence on the expression of interferon
(IFN)-γ, depending on the time-point of its presence dur-
ing activation: when norepinephrine was added before
activation, IFN-γ production decreased; when added after
activation, IFN-γ production increased [5]. The impor-
tance of this neuro-immunologic axis becomes even more
obvious in patients with spinal cord injury, which have an
impaired response to infections. In a mouse model it has
been shown that, depending on the level of spinal cord
injury, increased concentrations of circulating corticoster-
one and norepinephrine are present, which lead to an
impaired antibody synthesis [6]. However, β2-adrenergic
stimulation or cyclic adenosine-monophosphate (cAMP)
accumulation - which is a key signalling event caused by
this receptor - elicit in concert with other stimuli divergent
effects in B cell subsets concerning proliferation, B7-2 and
major histocompatibility complex II expression, differen-
tiation to antibody-secreting cells, and antibody produc-
tion [7]. Interestingly, the antibody production largely
depends on the duration of cAMP accumulation. Short
term elevation of the cellular cAMP concentration results
in an increase of antibody production, whereas a long
term elevation decreases antibody production [7]. A
recent work by Grebe et al. reported that β-blockers such
as nadolol enhance antiviral CD8+  T lymphocyte
responses in mice, suggesting an immuno-suppressive
effect of norepinephrine [8].
Dopamine is the metabolic precursor of norepinephrine.
The secondary lymphoid tissues are abundantly inner-
vated by the sympathetic nerves that store a large amount
of dopamine [9]. The D1 to D5 receptors for dopamine
are differentially expressed on leukocyte subsets [10-13],
and it has also been reported that dopamine can act via β-
adrenoceptors [14]. Dopamine suppresses the prolifera-
tion and cytotoxicity of T lymphocytes [15], but stimu-
lates adhesion to fibronectin [11]. With regard to the
cytokine release, the function of dopamine is not clear.
Depending on the experimental setting, dopamine has
been reported to have increasing [16] as well as decreasing
[17] function. In the first study, the peripheral blood
mononuclear cell (PBMC) fraction was activated with
anti-CD3 and anti-CD28 antibodies [16]. In the second
study, the T lymphocytes were further purified from the
PBMC fraction and activated only with an anti-CD3 anti-
body [17].
Substance P is a peptide of the neurokinin family, which
plays a role in depressive disorders [18], and inflamma-
tory processes [19,20]. Substance P is also released by
peripheral nerve endings that innervate lymphoid organs
[21]. In contrast to dopamine, substance P inhibits T lym-
phocyte adhesion to fibronectin [22], and in contrast to
norepinephrine, substance P increases the number of
immunglobulin-secreting cells [23].
Unfortunately, there exists no general scheme to predict
how neurotransmitter will act on leukocytes, in contrast
the effect of a neurotransmitter depends not only on the
parameter of interest but also on the cell type investigated
and its activation state or phenotype as well as on the lym-
phoid tissue from which the cells derive [22].
This brief introduction shows that norepinephrine,
dopamine and substance P have diverse, sometimes
opposite effects on B and Th lymphocytes. In comparison
to these lymphocyte subpopulations, the influence of
neurotransmitters on the function of CD8+ T lymphocytes
is much less investigated. Therefore, we conducted the
present study in order to complement the picture of neu-
rotransmitter action on leukocyte subsets. The CD8+ T
cells have to be activated in the lymph node by their T cell
receptor. They then emigrate from the lymph node,
extravasate from the blood stream at infected or inflamed
tissue sites and migrate through the tissue in search for tar-
get cells. After recognition of these cells, they eliminate
these cells. We investigated the influence of norepine-
phrine, dopamine and substance P on these key functions
of CD8+ T lymphocytes in vitro: activation, migration,
extravasation and cytotoxicity. Beyond this, we provide
molecular explanations on how the neurotransmitters
affect these cells functions.BMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
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Results and Discussion
Impact of neurotransmitters on the activation of CD8+ T 
lymphocytes depends on IL-2
CD8+ T lymphocytes were activated by cross-linking of the
T cell receptor molecules CD3 and CD28 by immobilized
antibodies. Activation was monitored by staining of the
classical activation markers CD45R0 and CD25. After four
days of activation 26.4 ± 6.6% of the CD8+ T lymphocytes
were double positive for CD45R0 and CD25 (Fig. 1A;
left). Norepinephrine and dopamine inhibited the activa-
tion to 16.4 ± 5.2% and 13.4 ± 6.2% of the cells, respec-
tively, whereas both effects were significant (p = 0.040 and
p = 0.026). Substance P led only to a slight, non-signifi-
cant reduction (25.5 ± 7.3% double-positive cells). This
inhibition of activation was not due to cell death, as we
have analyzed by flow-cytometry. IL-2 is a well known
cytokine in T cell activation, and consequently the exoge-
nous addition of IL-2 strongly supports the activation
process. The stepwise addition of IL-2 (0.1, 1, 10 and 100
ng/ml) had two effects: firstly, the more IL-2 was added,
the weaker the inhibitory effects of the neurotransmitters
were. Secondly, the number of CD45R0 and CD25 dou-
ble-positive T lymphocytes increased dose-dependently
(Fig. 1A; right). None of the investigated neurotransmit-
ters norepinephrine, dopamine or substance P had a sig-
nificant influence on the activation in the presence of 100
ng/ml IL-2 (Fig 1A). Thus, we asked, whether the neuro-
transmitters might have an effect on the IL-2 expression.
We analyzed the amount of IL-2 mRNA by semi-quantita-
tive RT-PCR after 24 hours of activation (Fig. 1B). Cells
treated with norepinephrine (10 μM) and dopamine (1
μM) showed a decrease in their level of IL-2 mRNA to
31% and 27%, respectively, when compared to control
cells and adjusted to β-actin expression. Substance P treat-
ment (1 μM) led to a moderate reduction to 86%, whereas
non-activated cells showed only 18% expression of IL-2
RNA when compared to their activated counterparts (Fig.
1B). The RT-PCR results were further verified by IL-2
ELISA experiments to investigate if protein expression and
secretion are also decreased. Therefore the cell culture
supernatant after two days of activation was collected.
Under control conditions CD8+ T lymphocytes secreted
26.62 ± 0.58 pg IL-2 per 2 × 106 cells per day (Fig. 1C). In
the presence of neurotransmitters the amount of secreted
IL-2 was decreased (norepinephrine 19.43 ± 1.8,
dopamine 15.94 ± 4.09, substance P 22.68 ± 0.67 pg IL-2
per 2 × 106  cells per day). Unactivated lymphocytes
secreted only a small amount of IL-2.
These results deliver an explanation for the reduction of
activation by the neurotransmitters, and it explains, why
no effects of the neurotransmitters were observed, when
IL-2 was added exogenously during activation. Norepine-
phrine and dopamine inhibit the IL-2 expression thus
interfering with the generation of an autocrine IL-2 loop
necessary for optimal activation of T cells.
The IL-2 promoter is under the control of several tran-
scription factors. We thus investigated, whether the neuro-
transmitters might inhibit one or more of these
transcription factors. Activator protein (AP)-1, nuclear fac-
tor of activated T-cells (NFAT), nuclear factor (NF)-κB,
and the cAMP response element binding protein (CREB)
are known to be necessary for optimal IL-2 gene transcrip-
tion [24]. Phosphorylated Erk1/2 leads to an up-regula-
tion of c-Fos expression [24,25] and c-Fos in turn, when
dimerized with the Jun family of transcription factors,
forms AP-1 [26]. Therefore, we investigated Erk1/2 phos-
phorylation as a marker for AP-1 activity (Fig. 2A). Erk1/2
phosphorylation was strongly reduced by norepinephrine
(p44 to 41% and p42 to 44%) and dopamine (p44 to
41% and p42 to 54%) and to a minor degree by substance
P (p44 and p42 to 64%; Fig. 2A). In the non-activated
control, no Erk1/2 phosphorylation was detectable.
We next investigated the phosphorylation of the transcrip-
tion factors p65 (NF-κB family) and CREB one hour after
activation. Both of these transcription factors were highly
phosphorylated in activated cells, and no differences in
the induction of phosphorylation were observed with any
of the used neurotransmitters (Fig. 2B). NF-κB is under
the control of IκB, which restricts NF-κB to the cytoplasm
and inhibits its DNA binding activity [27]. Upon activa-
tion of the CTL, IκB is phosphorylated and subsequently
degraded (Fig. 2C; upper part), thereby releasing NF-κB
and allowing its transition to the nucleus (Fig. 2C; lower
part). When adjusted to the whole amount of IκB, nore-
pinephrine reduced the phosphorylation to 42%,
dopamine to 46%, and substance P to 37% (whereas in
the non-activated cells 3% phosphorylation was meas-
ured). Due to this, a reduced degradation was detected in
activated CD8+ T lymphocytes. Compared to non-acti-
vated cells, only few IκB (16%) was detected in activated
cells. Under neurotransmitter treatment, the remaining
amount of IκB increased to 49% (norepinephrine), 36%
(dopamine), and 35% (substance P). In consequence, a
reduced amount of phosphorylated NF-κB was found in
the nuclear fraction of the lymphocytes when treated with
the neurotransmitters during activation: 39% with nore-
pinephrine, 58% with dopamine, and 55% with sub-
stance P (Fig. 2C; lower part).
Transcription factors of the NFAT family are activated by
calcium signalling via calmodulin/calcineurin. An
involvement of NFAT in the inhibition of IL-2 expression
is unlikely, since none of the neurotransmitters had a sig-
nificant influence on the intracellular calcium increase in
response to CD3/CD28 cross-linking (changes of the
cytosolic calcium concentration were measured by flowBMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
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Activation of CD8+ T lymphocytes with anti-CD3 and anti-CD28 antibodies Figure 1
Activation of CD8+ T lymphocytes with anti-CD3 and anti-CD28 antibodies. The activation status was detected by 
double-staining for the activation markers CD25 and CD45R0. (A) Flow-cytometrical analysis of CD8+ T lymphocytes activated 
in the presence of neurotransmitters (10 μM norepinephrine, 1 μM substance P and dopamine). The graph shows the mean 
values and standard deviation of double-positive T lymphocytes of four independent experiments with cells from different 
donors. Asterisks mark statistically significant changes (p < 0.05). Stepwise addition of external IL-2 reverses the inhibitory 
effect of the neurotransmitters, but in turn leads to a higher number of CD25+ CD45RO+ lymphocytes. (B) Expression of IL-2 
RNA during activation under the influence of neurotransmitters. RT-PCR was performed with cDNA in the dilution steps 
1:125 1:625 1:3125 and 1: 15625. Per lane, 10 μl of PCR sample were applied to the agarose gel. Beta-actin expression was 
used as house-keeping gene. (C) The release of IL-2 by CD8+ lympocytes during activation in the presence of neurotransmit-
ters was measured by using an enzyme-linked immunoassay. The graph shows mean values and standard deviation of three 
independent experiments with cells from different donors.BMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
Page 5 of 15
(page number not for citation purposes)
cytometrical analysis on the basis of a protocol described
by Gergely et al. [28]; data not shown).
T cell activation via CD3 and CD28 leads to activation of
associated kinases of the src-family and the recruitment
and activation of the tyrosine kinase ZAP-70 (ζ-chain
associated protein). With regard to IL-2 transcription two
key signalling pathways become activated. (1) phosphol-
ipase C gamma (PLCγ) is recruited to the membrane site
and becomes activated. PLCγ cleaves phosphatidylinositol
bisphosphate (PIP2) to yield inositol triphosphate (IP3)
and diacylglycerol (DAG). DAG activates NFκB via pro-
tein kinase θ and IP3 opens intracellular calcium storages.
The increased level of intracellular Ca2+ activates the ser-
ine phosphatase calcineurin, which dephosphorylates
NFAT. Dephosphorylated NFAT enters the nucleus. (2)
CD3 and CD28 signalling leads to the activation of Ras.
Ras induces the activation of the transcription factor AP-1
via the MAP kinase cascade Raf-1/MEK/ERK and further
mediates the degradation of IκB via AKT.
In summary we could show that those transcription fac-
tors, which are under the control of Ras, i.e. AP-1 and IκB,
are regulated by neurotransmitters [29,30], whereas those,
which are regulated by downstream signals of the PLCγ,
i.e. NF-κB and NFAT, are not affected [31,32].
Effect of neurotransmitters on the migratory behaviour
Activated CD8+ T lymphocytes showed a striking and sig-
nificant (p < 0.001) increase of the migratory activity from
14.5 ± 11.4% to 52.5 ± 13.2% locomoting cells after acti-
vation (Fig. 3A). Furthermore, we have reported previ-
ously, that the migratory activity of naïve, non-activated
CD8+ T cells is increased by the treatment with norepine-
phrine or substance P [33]. Likewise, dopamine signifi-
cantly (p = 0.034) increased the migratory activity from
13.6 ± 3.8% to 27.6 ± 9.6% locomoting cells (Fig. 3B). In
contrast to these results, the migratory activity of activated
T lymphocytes was reduced by norepinephrine and sub-
stance P, whereas dopamine had no effect (Fig. 4A to 4C).
Norepinephrine almost significantly (p = 0.061) reduced
the migration of activated CD8+ T cells from 47.5 ± 4.6%
to 32.6 ± 8.9% locomoting cells (Fig. 4A). Dopamine had
no effect on the migratory activity (51.5 ± 16.8% locomot-
ing cells control vs. 53.6 ± 0.9% locomoting cells; Fig. 4B).
Substance P reduced the migration from 58.6 ± 17.4 to
48.9 ± 18.9% locomoting cells (Fig. 4C); this effect was
however not significant due to the high standard devia-
tion. These differences might be due to the fact, that
dopamine receptors are down-regulated on activated
CD8+ T lymphocytes as we found by western blot analysis,
whereas the β1-adrenoceptor and the NK-1 receptor are
still expressed by activated cells (Fig. 3C). We found only
the D3 and D4 receptors and to a lesser degree the D5
receptor to be expressed on naïve CD8+ T lymphocytes. All
Transcription factor activation Figure 2
Transcription factor activation. (A) Immunoblots of 
total Erk1/2 and phosphorylated Erk1/2, (B) immunoblots of 
total and phosphorylated p65 and CREB, and (C) immunob-
lots of total and phosphorylated IκBα in CTL during activa-
tion, and of phospho-NF-κB in the nuclear fraction. β-Actin 
and Lamin A/C concentrations were used as standards to 
adjust the applied protein amounts. Abbreviations are: Con = 
control; Nor = norepinephrine; Dop = dopamine; SubP = 
substance P; na = non-activated control. (D) Neurotransmit-
ters were added at 10 μM (norepinephrine) and 1 μM (sub-
stance P and dopamine) in all experiments.BMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
Page 6 of 15
(page number not for citation purposes)
Migratory activity of CD8+ T lymphocytes Figure 3
Migratory activity of CD8+ T lymphocytes. Each graph shows on the left side the time-course of the mean migratory 
activity and on the right side the time-average of the migratory activity as mean value and standard deviation of the same 
experiments. In (A), nine experiments were performed with activated and naive CD8+ T lymphocytes, in (B) four experiments 
were performed with naïve CD8+ T lymphocytes (1 μM dopamine). For each experiment, blood from different donors was 
used. Asterisks mark statistically significant changes (p < 0.05). (C) Shows the western blot analysis of the neurotransmitter 
receptors expressed on naïve and activated CD8+ T lymphocytes. β-Actin served as loading control.BMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
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Migratory activity of activated CD8+ T lymphocytes Figure 4
Migratory activity of activated CD8+ T lymphocytes. Each graph shows on the left side the time-course of the mean 
migratory activity and on the right side the time-average of the migratory activity as mean value and standard deviation of the 
same experiments. Three experiments were performed with each neurotransmitter: (A) 10 μM norepinephrine, (B) 1 μM 
dopamine, (C) 1 μM substance P. For each experiment, blood from different donors was used. Asterisks mark statistically sig-
nificant changes (p < 0.05).BMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
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three of them become down-regulated during T cell acti-
vation and with the exception of the D5 receptor these
findings are in accordance with Watanabe et al. [12].
Thus, naïve and activated CD8+ T lymphocytes differ in
their level of spontaneous migratory activity. In the naïve
state the spontaneous migratory activity is only moderate
whereas in the activated state more than half of the cells
show migratory activity. This observation is not surprising
since the expression pattern of matrix adhesion molecules
changes during the activation process and thereby the
intracellular signalling. Consequently, neurotransmitters
have distinct effects on naïve and activated CD8+ T lym-
phocytes. Collagen I receptors such as very late antigen
(VLA)-1 and VLA-2 are almost absent on naïve CD8+ T
cells but become upregulated during activation [34,35].
This might explain our observation that the naïve lym-
phocytes show less spontaneous migratory activity than
the activated lymphocytes in our migration assay contain-
ing 95-98% collagen I as almost single matrix component,
with the remainder being comprised of type III collagen.
Naïve CD8+ T lymphocytes show an increase in their
migratory activity in response to dopamine (Fig. 3B),
norepinephrine and substance P [33], with dopamine
being the strongest inducer. Our finding on dopamine is
consistent with Watanabe et al. [12], who described that
dopamine induces chemotaxis in CD45RA+ naïve CD8+
cells via D3 receptor and postulated a role for endogenous
dopamine in the homing of naïve CD8+ T cells.
Adhesion of CTL to endothelium is selectively regulated by 
neurotransmitters
The ability to extravasate is an important property of
immune cells independent of their activation state. Naïve
lymphocytes need to extravasate during the homing proc-
ess and activated cells extravasate in order to reach tissue
sites of inflammation or injury. The idea that neurotrans-
mitters influence the extravasation process seems likely,
because nerve fibres are particularly concentrated around
vascular endothelial cells [9]. Non-activated CD8+ T lym-
phocytes show only low adhesion to the endothelium,
but a high rolling activity, as we have investigated by our
flow-through adhesion assay (Fig. 5). In activated CD8+ T
lymphocytes, the adhesion significantly (p < 0.001)
increased from 25.3 ± 2.5 to 104.7 ± 7.4 cells (average val-
ues of Fig. 5A to 5C). Due to the increased adhesion, the
rolling activity is reduced. Both adhesion and rolling of
activated CD8+ cells is increased by addition of each of the
investigated neurotransmitters directly to the experiment.
Norepinephrine significantly (p = 0.007) increased the
adhesion of the activated cells from 102 ± 17 to 154 ± 3
cells (Fig. 5A). Likewise, the rolling was significantly (p =
0.032) increased from 49 ± 3 to 59 ± 5 cells/min (Fig. 5A).
Dopamine and substance P enhanced the adhesion and
rolling of the activated cells only marginally, which was
not statistically significant (Fig. 5B and 5C). With regard
to naïve, non-activated CD8+ cells, all of the investigated
neurotransmitters had only minor effects. However,
dopamine significantly (p = 0.014) increased the adhe-
sion of the naïve, non-activated cells (Fig. 5B), whereas
substance P led to a significant reduction (p = 0.004; Fig.
5C). With regard to dopamine, the finding is in accord-
ance with results from other groups who described an
increase in the adhesion of naïve CD45RA+ CD8+ lym-
phocytes to fibronectin and ICAM-1 in response to
dopamine but not substance P [12,22]. This effect was
exclusively mediated by the D3 receptor and led to an acti-
vation of the fibronectin receptors VLA-4 and VLA-5 [22],
and the intercellular adhesion molecule (ICAM)-1 recep-
tor lymphocyte function-associated antigen (LFA)-1 [12]
on naïve lymphocytes. Thus dopamine seems to exhibit a
unique function leading to the activation of integrin mol-
ecules in naïve CD8+ cells which cannot be induced by
norepinephrine or substance P. This observation supports
the theory of dopamine being a specific homing factor of
naïve CD45RA+ CD8+ cells [12].
Since the neurotransmitters were added directly to the cell
suspension at the beginning of each experiment both cell
types involved - the lympocytes as well as the endothelial
cells- are exposed to the substance. Interestingly, nore-
pinephrine, but not dopamine or substance P induced a
significant (p = 0.013) increase of the IL-8 release from the
endothelial cells (from 62.4 ± 24.1 to 182.9 ± 42.8 ng/ml;
Fig. 6A), even when pre-activated with the cytokine IL-1β
(since already IL-1β treatment alone leads to an increase
of IL-8 release). Chemokines such as IL-8 are cationic pro-
teins, which bind to heparansulfate and related gly-
cosaminoglycan moieties on the endothelial monolayer
[36,37], and thereby becomes presented to rolling cells.
Several studies have conclusively shown that the recruit-
ment of circulating leukocytes at vascular sites in target tis-
sue is linked to activation of Gi-protein signalling in
leukocytes induced by chemokines presented on the api-
cal site of the endothelial monolayer (reviewed in [38]).
These immobilized chemokines are involved in the rapid
modulation of the avidity of integrins such as VLA-4 [39]
or LFA-1 expressed by lymphocytes. To confirm this
hypothesis, we investigated the surface expression of the
according IL-8 receptors CXCR1 and CXCR2 on CD8+
lymphocytes: CXCR1 was almost absent on naïve cells
(3.5% CXCR1+ cells), but it became upregulated during
activation (45.3% CXCR1+ cells; Fig. 6B). We did not
detect an expression of the IL-8 receptor CXCR2 neither
on naïve nor on activated CD8+ T lymphocytes (data not
shown), which corresponds to the results of Takata et al.
[40] and Nishimura et al. [41], but is in conflict with other
findings [42]. To investigate a possible role for CXCR1 in
the adhesion of CD8+ T lymphocytes to endothelium inBMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
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Interaction of CD8+ T lymphocytes with endothelial cells in a flow-through extravasation assay Figure 5
Interaction of CD8+ T lymphocytes with endothelial cells in a flow-through extravasation assay. The left columns 
of each graph show the adhesion and rolling of non-activated cells, the right columns show the adhesion and rolling of activated 
cells. "Adhesion" is the total number of tightly adherent cells in a 20 minute observation period. "Rolling" is the number of cells 
per minute, which rolled on the endothelium before they either tightly adhered or were washed away. Graphs show mean val-
ues and standard deviation of three independent experiments for each neurotransmitter: (A) 10 μM norepinephrine, (B) 1 μM 
dopamine, and (C) 1 μM substance P. Asterisks mark statistically significant changes (p < 0.05).BMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
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IL-8 in the interaction of CD8+ T lymphocytes and endothelium Figure 6
IL-8 in the interaction of CD8+ T lymphocytes and endothelium. (A) The release of IL-8 from the endothelium in 
response to the investigated neurotransmitters (10 μM norepinephrine, 1 μM substance P and dopamine) was measured using 
an enzyme-linked immunoassay. The graph shows mean values and standard deviation of four independent experiments with 
cells from different donors. Asterisks mark statistically significant changes (p < 0.05). (B) Flow-cytometrical measurement of 
the CXCR1 expression on activated and naïve CD8+ T lymphocytes. The cells were distinguished for their activation state by 
CD25 and CD45R0 expression (left). Each subpopulation was characterized for CXCR1 expression separately (right). (C) 
Extravasation experiments were performed with a blockade of the IL-8 receptors on the activated CD8+ T lymphocytes by 
receptor-specific antibodies (abCXCR1+2). Isotypic antibodies (IgG2a) were used as control. Graphs show mean values and 
standard deviation of four independent experiments with cells from different donors. Asterisks mark statistically significant 
changes (p < 0.05).BMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
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the presence of norepinephrine we blocked this receptor,
and CXCR2 as well (because of the conflicting reports that
the CXCR2 is expressed on activated CD8+ cells [42]), via
a specific blocking antibody (Fig. 6C). This blockade led
to a significant (p = 0.022) reduction of the activated
CD8+ T lymphocyte adhesion to the endothelial cells in
the presence of norepinephrine compared to the isotype
(IgG2a) control from 165 ± 11 to 115 ± 24 adherent cells.
This reduction was however not completely down to the
control level (99 ± 7 and 74 ± 6 adherent cells with IgG2a
and CXCR1/2 blocking antibodies, respectively; Fig. 6C).
Thus, the effect of norepinephrine on the adhesion of acti-
vated CD8+ T lymphocytes shown in Fig. 5A is not only
mediated by IL-8. Instead the effect can be further medi-
ated by other chemokines released by the endothelium or
by a direct effect of norepinephrine on the T cells. Since we
have just screened a subset of chemokines released by
endothelial cells, we cannot exclude that the release of fur-
ther chemokines is affected by norepinephrine.
From our experiments, we can exclude that substance P
and dopamine as well act in the way as norepinephrine
does, since these neurotransmitters do not result in an
increased release of IL-8 from the endothelium.
Degranulation is not influenced by neurotransmitters
The effects of the neurotransmitters on the ability of the
cells to degranulate were measured by β hexosamidase
release (Fig. 7) in response to CD3 cross-linking, which
mimics the recognition of a target cells without CD28 co-
signalling. This process results in a calcium-dependent
release of cytotoxic enzymes from intracellular granules
that have been formed during activation. In naïve CD8+ T
lymphocytes, the CD3-induced release of β hexosamidase
is as high as the release induced by an isotypic control
antibody (Fig. 7; left). After activation, the CD3-induced
release of β hexosamidase is significantly (p = 0.017)
increased from 29.1 ± 5.8% to 43.9 ± 6.3% release. How-
ever, none of the investigated neurotransmitters caused
any effect in activated CD8+ T lymphocytes (Fig. 7). Deter-
mination of the calcium-signalling in response to CD3
cross-linking showed no differences, too (data not
shown). In conclusion, it seems that the investigated neu-
rotransmitters can affect the development of armed effec-
tor cells, but when these cells once have been formed, they
cannot be inhibited in their effectory function by neuro-
transmitters.
Conclusion
Although we have large and detailed knowledge how cer-
tain neurotransmitters act on particular leukocyte sub-
populations, the remaining question is still how emotions
and sensations are translated into modulatory effects of
the immune system, and whether this at all plays a role in
the function of the immune system [43].
Taken together, we have addressed the question how the
neurotransmitters norepinephrine, dopamine and sub-
stance P influence the function of CD8+ T lymphocytes.
We have identified a regulation pattern (Table 1) showing
that neurotransmitters can act either immunostimulatory
or immunosuppressive. This depends mainly on the acti-
vation state of the T cells. We were able to assign down-
stream targets of the observed effects. Neurotransmitters
cannot  per se induce new functions in CD8+  T lym-
phocytes, i.e. migration, adhesion and cytotoxicity, but
they play an important role in the fine-tuning of T cell
responses.
Methods
Cell isolation and activation
CD8+ cells were isolated from heparinised human periph-
eral blood by a two step procedure. First, the lymphocyte-
containing PBMC fraction was isolated by a density gradi-
ent centrifugation on lymphocyte separation medium
Cytotoxicity of CD8+ T lymphocytes as measured by β-hex- osamidase release Figure 7
Cytotoxicity of CD8+ T lymphocytes as measured by 
β-hexosamidase release. CD8+ T lymphocytes were stim-
ulated to release cytotoxic granules by CD3 cross-linking 
(black columns). A non-cross-linking isotypic IgG2a antibody 
was used as control (IgG; white columns). The graph shows 
mean values and standard deviation of five independent 
experiments with cells from different donors. Asterisks mark 
statistically significant changes (p < 0.05).
Table 1: Summary of neurotransmitter effects on CD8+ T 
lymphocytes
Norepi Dopamine Sub P
Activation ↓↓ ↓↓ --
Migration naive ↑ ↑↑↑ ↑
activated ↓↓ -- ↓
Adhesion to naive -- ↑↑↑ ↓↓
endothelium activated ↑↑↑ ↑ ↑
Degranulation activated -- -- --BMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
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(LSM 1077; PAA, Pasching, Austria). Subsequently, CD8+
T lymphocytes were positively selected from the mononu-
clear fraction by immunomagnetic beads, which were
coated with mouse anti-human CD8 monoclonal anti-
bodies (Dynabeads; Invitrogen, Karlsruhe, Germany). The
mononuclear cell fraction was incubated with the beads
for 10 minutes at 4°C. Bead-bound cells were isolated by
eight times washing with Dulbecco's PBS (PAA) in a mag-
netic field. After that, the beads were removed from the
isolated T lymphocytes using Detachabeads (Invitrogen)
at incubation for 45 minutes at 20°C. The purified cells
were more than 99% CD3 positive and more than 97%
positive for CD8, as detected by flow cytometry.
The isolated CD8+ T lymphocytes were activated by anti-
CD3 and anti-CD28 antibodies (both BD Pharmingen,
Erembodegem, Belgium). Multi-well plates according to
the kind of experiment were coated with 10 μg/ml of each
of these antibodies in PBS at 4°C over night. Cells were
seeded at a concentration of 8 × 105 cells/ml in RPMI with
10% FCS and 1% penicillin/streptomycin solution (all
components were from PAA, Pasching, Austria). The cells
were incubated for three days, without or with the daily
addition of 0.1, 1, 10 or 100 ng/ml IL-2 (Invitrogen, Niv-
elles, Belgium). Maximum activation of the cells (as meas-
ured by the activation markers) was reached after four
days, but the granularity (as measured by the sideward
scatter) reached the maximum already after three days and
decreased to day four.
In addition, the neurotransmitters norepinephrine (10
μM; Sigma-Aldrich, Taufkirchen, Germany), substance P
(1 μM; Calbiochem, Bad Soden, Germany) and dopamine
(1 μM; Sigma-Aldrich) were added each day. These were
the lowest concentrations with maximum effect with
regard to cell migration and activation (data not shown).
The same concentrations were used in publications on
CD8+ T lymphocytes and natural killer cells [33], as well
as neutrophil granulocytes and tumor cells [44-46]. The
blood and plasma concentrations of the neurotransmit-
ters used herein are usually reported to be 10 to 1,000 fold
lower than those concentrations that we have used in our
experiments, but local concentrations of the neurotrans-
mitters can be much higher, e.g. the norepinephrine level
was found to reach 500 μM at nerve terminals [47].
Flow cytometry
Besides the above mentioned analysis of the purity of iso-
lated CD8+ T lymphocytes, flow cytometrical measure-
ments were performed for the detection of the activation
status of the cells using a FACSCalibur flow cytometer
(Becton Dickinson, Heidelberg, Germany). The activation
status of the cells was analysed by measuring the activa-
tion markers CD25 and CD45R0 with a fluorescein isothi-
ocyanate (FITC)-coupled anti-human CD25 antibody and
a phycoerythrin (PE)-coupled anti-human CD45R0 anti-
body (both Coulter Immunotech, Marseille, France). To
determine changes of the CXCR1 expression during acti-
vation, cells were stained with a mouse anti-human
CXCR1 or CXCR2 antibody (R&D Systems, Wiesbaden,
Germany), and detected with Cy5-conjugated Fab frag-
ment goat anti-mouse IgG (Dianova, Hamburg, Ger-
many). In addition, the part of dead and viable cells was
measured by propidium iodide staining.
Immunoblotting
For the investigation of transcription factor activation,
immunoblotting with phospho-specific antibodies was
performed. Samples of 3 × 105 cells were incubated in 96-
well plates coated with anti CD3- and anti CD28 antibod-
ies or mouse IgG1 isotype control as described above.
After the indicated time points the plates were spun down
at 1200 rpm for 2 min. The supernatant was removed and
cell lysis was performed using 30 μl of Laemmli buffer
without  β-mercaptoethanol. Lysates were incubated at
95°C 10 min prior to application to gel electrophoresis
according to Laemmli [48]. The proteins were transferred
to an Immobilion-P membrane (Millipore, Bedford,
Mass.) [49], and immunoblotting was performed as
described previously [44]. Phospho(Thr202/Tyr204)-
Erk1/2, Erk1/2, phospho(Ser536)-p65, p65, phos-
pho(Ser133)-CREB, CREB, Lamin A/C, phospho(Ser32)-
IκBα, IκBα, and β-actin antibodies were obtained from
New England Biolabs (Frankfurt a. M., Germany) and
used at a concentration of 1:1,000 for Erk1/2, CREB and
Lamin A/C, 1:500 for phospho-p65, p65, phospho-IκBα
and Iκ Bα, and 1:2,000 for β-actin. Primary antibodies
were detected using horseradish peroxidase-conjugated
secondary anti-mouse or anti-rabbit antibodies (Southern
Biotech, Birmingham, AL) at a concentration of 1:10,000.
The luminescence signal was induced with chemilumines-
cence blotting substrate (Roche, Mannheim, Germany)
and detected using a Hamamatsu C4742-98 system
(Hamamatsu, Herrsching, Germany). Staining signals
were quantified using the ImageJ software (NIH,
Bethesda, MD). After detection of phospho-proteins
membranes were stripped and reprobed with the corre-
sponding non-phospho-antibody or antibodies against β-
actin and Lamin A/C as standards.
For isolation of the nuclear fraction, hypotonic lysis was
performed for 15 min on ice in 10 mM HEPES, 1.5 mM
MgCl2, 1.5 mM NaF, 1 mM Na3VO4, 1 mM PMSF, pro-
tease inhibitor cocktail (Sigma-Aldrich), and 0.5% Triton
X-100. Nuclei were collected by centrifugation at 14,000 g
at 4°C and resuspended in Laemmli buffer without β-
mercaptoethanol.
For the analysis of neurotransmitter receptors on naïve or
activated CD8+ T cells we used the following antibodiesBMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
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from Santa Cruz Biotechnology (Santa Cruz, California)
at a dilution of 1:500: Goat anti NK-1R (clone N-19), goat
anti D1DR (clone C-20), rabbit anti D2DR (clone H-50),
rabbit anti D3DR (clone H-50), goat anti D4DR (clone N-
20), goat anti D5DR (clone C-20), rabbit anti β1-adrener-
gic receptor (clone V-19), rabbit anti β1-adrenergic recep-
tor (clone H-20).
Semi-quantitative RT-PCR
Cells were activated in anti-CD3- and anti-CD28-coated
wells with or without neurotransmitters for 24 h. Total
RNA from 5 × 106 cells per sample was isolated using the
Macherey Nagel total RNA isolation kit XS (Düren, Ger-
many). An amount of 1.5 μg RNA was used for first-strand
cDNA synthesis (Fermentas, St. Leon-Rot, Germany).
cDNA samples were fivefold diluted serially (1:125;
1:625; 1:3,125; 1:15,625) and analyzed by semi-quantita-
tive reverse transcriptase PCR using the following primers
(5'→3'): IL-2, Fwd-ACTCACCAGGATGCTCACAT and
Rev-AGGTAATCCATCTGTTCAGA;  β-actin, Fwd-GTGGG
GCGCCCCAGGCACCA and Rev-CTCCTTAATGTCACG-
CACGATTTC [50]. Primers were chosen to ensure the tem-
plate spanning at least one intron so that any genomic
DNA contamination would result in a larger product
band. PCR products were visualized on a 1% ethidium
bromide agarose gel.
Migration
We performed our conventional three-dimensional, colla-
gen-based migration assay as described in detail previ-
ously [51]. In brief, a suspension of 2 × 105 CD8+ T
lymphocytes in 50 μl RPMI with or without neurotrans-
mitters was mixed with 100 μl of a buffered collagen solu-
tion (pH 7.4), containing 1.67 mg/ml bovine collagen
type I (Invitrogen, Cohesion Technologies, Palo Alto,
CA). The suspension was filled into self constructed
migration chambers, which consist of a microscopic glass
slide, wax walls, and a cover slip on top. After polymeriza-
tion of the collagen at 37°C in a humidified 5% CO2
atmosphere, the migration of the cells was recorded by
time-lapse videomicroscopy for 1 hour at 37°C. The paths
of 30 randomly selected cells were digitized by computer-
assisted cell tracking and the part of migratory active cells
was calculated for each one minute interval [51].
Flow-through adhesion assay
We have recently developed a new adhesion assay under
flow conditions on the basis of the above described migra-
tion assay [52]. Human endothelial cells from the pulmo-
nary microvasculature (HMVEC; Lonza, Verviers,
Belgium) were used for the generation of a vascular struc-
ture. The cells were cultured up to six passages in EBM-2
medium with supplements (Lonza) in a humidified
atmosphere at 5% CO2. For the experiments the HMVECs
were seeded on collagen IV-coated flow chambers (μ-
chamber I, IBIDI, Munich, Germany) in normal culture
medium and incubated to confluency for two days. Before
each experiment, the endothelium was activated by treat-
ment with 10 ng/ml IL-1β (Invitrogen, Nivelles, Belgium)
for 4 hours. The activated T lymphocytes (3 × 105 cells/ml
in endothelial basal medium (PAA) with 2% fetal calf
serum) were drawn through the flow chamber by a per-
fusion pump (Perfusor IV, B. Braun Melsungen AG, Mel-
sungen, Germany) at a flow rate of 12.2 ml/h, which
results in a shear stress of 0.25 dyne/cm2 and represents
physiological blood flow conditions in small vessels. The
investigated neurotransmitters were added directly to the
experiments at 10 μM for norepinephrine and 1 μM for
dopamine and substance P. In blocking experiments, the
IL-8 receptors CXCR1 and CXCR2 on CD8+ T lymphocytes
were blocked with mouse anti-human antibodies pro-
vided by R&D Systems at a concentration of 5 μg/ml each
for 15 min prior to an experiment, IgG2a mouse-antibody
served as isotype control. The suspension flow was digit-
ally recorded by a video-camera mounted on the micro-
scope and a connected computer. The number of adhesive
cells and of rolling cells was analyzed. The adhesive cells
were counted as the absolute number during the entire
recording period of 20 minutes. The rolling cells were cal-
culated per minute.
Cytokine ELISA
To estimate the amount of secreted IL-2 2 × 106 CD8+ T
lymphocytes were activated for two days in 250 μl culture
medium with or without neurotransmitters.
The amount of IL-8 secreted by HMVEC was estimated
after stimulation of cell monolayers with 10 μM norepine-
phrine, 1 μM dopamine or 1 μM substance P alone or in
combination with 10 ng/ml IL-1β (Invitrogen) for 4 hours
in media without supplements.
Supernatant was collected and the concentration of IL-2
and IL-8 was measured by enzyme-linked immunoassays
using the Quantakine kits (R&D Systems) according to the
manufacturers protocol.
Degranulation measured by  -hexosamidase release
The β-hexosamidase assay was performed as described by
Shen et al. [53] with some modifications. Briefly, CD8+ T
lymphocytes were plated in a 96-well plate (3.5 × 105
cells/well), which was coated with an anti-CD3 or IgG2a
antibody, and cultured in 100 μl RPMI (w/o FCS and Phe-
nolRed) containing the neurotransmitter at above men-
tioned concentration. After 4 hours, the cells were
harvested by centrifugation and 50 μl of the supernatant
were mixed with 150 μl of a 1 mM para-nytrophenyl N-
acetyl-β-D glucosamide (Sigma-Aldrich) solution in 0.1 M
citrate buffer (pH 4.5). After 2 hours of incubation at
37°C the reaction was stopped by addition of 100 μl of 1BMC Immunology 2009, 10:62 http://www.biomedcentral.com/1471-2172/10/62
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M Na2CO3. Absorbance was read at 405 nm using a Model
550 microplate reader (Bio-Rad Laboratories, Hercules,
CA). Maximum release (positive control) was induced by
cell lysis with 1% Triton X-100. β-Hexosamidase release
was calculated as the percentage of total enzyme activity in
Triton X-100-treated samples.
Statistics
Significant changes were calculated using the Student's t
test (two-tailed, unpaired). A probability value of p < 0.05
was accepted as statistically significant throughout the
experiments.
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